DA
Diagnósticos da América S.A.
DASA3.SA · SAO
R$ 2.81 -2.09% (-R$ 0.06)
1M +34.11%
Market Cap R$ 3.62B
P/E Ratio -
Div. Yield -
ROE 12.61%
Bulios Fair Price
R$ 1.43
49.1% downside
Current Price
R$ 2.81
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DASA3.SA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
93 /100
Cheap P/S 0.39x
P/B 0.53x
P/FCF 16.53x
Growth
4 /100
Declining Book val. growth 1.02%
Rev. growth 5.24%
FCF growth N/A
Profitability
31 /100
Weak Net margin 9.60%
Op. margin 11.01%
FCF margin 2.35%
Quality
25 /100
Poor ROE 12.61%
ROA 5.23%
Asset turnover 0.54x
Debt
39 /100
Moderate Current ratio 1.27x
Int. coverage 0.85x
Net debt/EBITDA 3.12x
Stability
25 /100
Unstable Rev. volatility 20.29%
EPS volatility 86.81%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DASA3.SA
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rafael Lucchesi
Employees
26,255
Headquarters
São Paulo
Upcoming events
05 NOV
Earnings
Upcoming earnings report